vs
Ingevity Corp（NGVT）与Bio-Techne（TECH）财务数据对比。点击上方公司名可切换其他公司
Bio-Techne的季度营收约是Ingevity Corp的1.6倍（$295.9M vs $185.4M），Bio-Techne净利率更高（12.8% vs -45.6%，领先58.5%），Ingevity Corp同比增速更快（36.7% vs -6.4%），过去两年Bio-Techne的营收复合增速更高（4.2% vs -26.2%）
Ingevity Corp是一家全球特种化学品与先进材料生产商，主营高性能碳材料、路面养护解决方案及特种化工产品，服务汽车排放控制、工业净化、道路基建、农业投入品等核心市场，业务覆盖北美、欧洲及亚太地区。
Bio-Techne是美国头部生命科学企业，面向科研、诊断及生物工艺市场需求，研发、生产并销售生命科学试剂、仪器及配套服务，产品及解决方案广泛应用于基础研究、体外诊断、生物医药研发生产等场景，可为相关领域从业者提供可靠的专业工具支持。
NGVT vs TECH — 直观对比
营收规模更大
TECH
是对方的1.6倍
$185.4M
营收增速更快
NGVT
高出43.1%
-6.4%
净利率更高
TECH
高出58.5%
-45.6%
两年增速更快
TECH
近两年复合增速
-26.2%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $185.4M | $295.9M |
| 净利润 | $-84.6M | $38.0M |
| 毛利率 | 41.2% | 64.6% |
| 营业利润率 | -47.7% | 18.4% |
| 净利率 | -45.6% | 12.8% |
| 营收同比 | 36.7% | -6.4% |
| 净利润同比 | -609.6% | 68.3% |
| 每股收益（稀释后） | $-2.33 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NGVTTECH
| Q4 25 | $185.4M | $295.9M | ||
| Q3 25 | $333.1M | — | ||
| Q2 25 | $365.1M | $317.0M | ||
| Q1 25 | $284.0M | $316.2M | ||
| Q4 24 | $135.6M | $297.0M | ||
| Q3 24 | $333.8M | $289.5M | ||
| Q2 24 | $390.6M | $306.1M | ||
| Q1 24 | $340.1M | $303.4M |
净利润NGVTTECH
| Q4 25 | $-84.6M | $38.0M | ||
| Q3 25 | $43.5M | — | ||
| Q2 25 | $-146.5M | $-17.7M | ||
| Q1 25 | $20.5M | $22.6M | ||
| Q4 24 | $16.6M | $34.9M | ||
| Q3 24 | $-107.2M | $33.6M | ||
| Q2 24 | $-283.7M | $40.6M | ||
| Q1 24 | $-56.0M | $49.1M |
毛利率NGVTTECH
| Q4 25 | 41.2% | 64.6% | ||
| Q3 25 | 40.2% | — | ||
| Q2 25 | 37.8% | 62.7% | ||
| Q1 25 | 39.9% | 67.9% | ||
| Q4 24 | 81.3% | 65.3% | ||
| Q3 24 | 39.4% | 63.2% | ||
| Q2 24 | 31.5% | 66.4% | ||
| Q1 24 | 29.3% | 67.4% |
营业利润率NGVTTECH
| Q4 25 | -47.7% | 18.4% | ||
| Q3 25 | 18.7% | — | ||
| Q2 25 | -39.1% | -7.5% | ||
| Q1 25 | 9.4% | 12.2% | ||
| Q4 24 | — | 16.0% | ||
| Q3 24 | 33.0% | 13.8% | ||
| Q2 24 | 25.9% | 15.0% | ||
| Q1 24 | 22.6% | 22.1% |
净利率NGVTTECH
| Q4 25 | -45.6% | 12.8% | ||
| Q3 25 | 13.1% | — | ||
| Q2 25 | -40.1% | -5.6% | ||
| Q1 25 | 7.2% | 7.1% | ||
| Q4 24 | 12.2% | 11.7% | ||
| Q3 24 | -32.1% | 11.6% | ||
| Q2 24 | -72.6% | 13.3% | ||
| Q1 24 | -16.5% | 16.2% |
每股收益（稀释后）NGVTTECH
| Q4 25 | $-2.33 | $0.24 | ||
| Q3 25 | $1.18 | — | ||
| Q2 25 | $-4.02 | $-0.11 | ||
| Q1 25 | $0.56 | $0.14 | ||
| Q4 24 | $0.44 | $0.22 | ||
| Q3 24 | $-2.94 | $0.21 | ||
| Q2 24 | $-7.81 | $0.26 | ||
| Q1 24 | $-1.54 | $0.31 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $78.1M | $172.9M |
| 总债务越低越好 | $1.2B | $260.0M |
| 股东权益账面价值 | $29.7M | $2.0B |
| 总资产 | $1.7B | $2.5B |
| 负债/权益比越低杠杆越低 | 39.10× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资NGVTTECH
| Q4 25 | $78.1M | $172.9M | ||
| Q3 25 | $83.4M | — | ||
| Q2 25 | $76.9M | $162.2M | ||
| Q1 25 | $71.5M | $140.7M | ||
| Q4 24 | $68.0M | $177.5M | ||
| Q3 24 | $135.5M | $187.5M | ||
| Q2 24 | $107.4M | $152.9M | ||
| Q1 24 | $88.5M | $145.3M |
总债务NGVTTECH
| Q4 25 | $1.2B | $260.0M | ||
| Q3 25 | $1.2B | — | ||
| Q2 25 | $1.2B | $346.0M | ||
| Q1 25 | $1.3B | $330.0M | ||
| Q4 24 | $1.3B | $300.0M | ||
| Q3 24 | $1.4B | $300.0M | ||
| Q2 24 | $1.4B | $319.0M | ||
| Q1 24 | $1.4B | $389.0M |
股东权益NGVTTECH
| Q4 25 | $29.7M | $2.0B | ||
| Q3 25 | $138.1M | — | ||
| Q2 25 | $120.7M | $1.9B | ||
| Q1 25 | $234.6M | $2.0B | ||
| Q4 24 | $195.2M | $2.1B | ||
| Q3 24 | $214.5M | $2.1B | ||
| Q2 24 | $284.8M | $2.1B | ||
| Q1 24 | $568.2M | $2.0B |
总资产NGVTTECH
| Q4 25 | $1.7B | $2.5B | ||
| Q3 25 | $1.8B | — | ||
| Q2 25 | $1.9B | $2.6B | ||
| Q1 25 | $2.1B | $2.6B | ||
| Q4 24 | $2.0B | $2.7B | ||
| Q3 24 | $2.2B | $2.7B | ||
| Q2 24 | $2.3B | $2.7B | ||
| Q1 24 | $2.6B | $2.7B |
负债/权益比NGVTTECH
| Q4 25 | 39.10× | 0.13× | ||
| Q3 25 | 8.39× | — | ||
| Q2 25 | 10.24× | 0.18× | ||
| Q1 25 | 5.68× | 0.16× | ||
| Q4 24 | 6.86× | 0.14× | ||
| Q3 24 | 6.52× | 0.14× | ||
| Q2 24 | 4.92× | 0.15× | ||
| Q1 24 | 2.48× | 0.19× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $97.1M | — |
| 自由现金流经营现金流 - 资本支出 | $73.5M | — |
| 自由现金流率自由现金流/营收 | 39.6% | — |
| 资本支出强度资本支出/营收 | 12.7% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $273.5M | — |
8季度趋势，按日历期对齐
经营现金流NGVTTECH
| Q4 25 | $97.1M | — | ||
| Q3 25 | $129.7M | — | ||
| Q2 25 | $79.0M | $98.2M | ||
| Q1 25 | $25.4M | $41.1M | ||
| Q4 24 | $64.5M | $84.3M | ||
| Q3 24 | $46.5M | $63.9M | ||
| Q2 24 | $29.7M | $75.5M | ||
| Q1 24 | $-12.1M | $81.0M |
自由现金流NGVTTECH
| Q4 25 | $73.5M | — | ||
| Q3 25 | $117.8M | — | ||
| Q2 25 | $66.8M | $93.3M | ||
| Q1 25 | $15.4M | $31.0M | ||
| Q4 24 | $39.6M | $77.5M | ||
| Q3 24 | $28.5M | $54.7M | ||
| Q2 24 | $11.6M | $57.5M | ||
| Q1 24 | $-28.7M | $64.5M |
自由现金流率NGVTTECH
| Q4 25 | 39.6% | — | ||
| Q3 25 | 35.4% | — | ||
| Q2 25 | 18.3% | 29.4% | ||
| Q1 25 | 5.4% | 9.8% | ||
| Q4 24 | 29.2% | 26.1% | ||
| Q3 24 | 8.5% | 18.9% | ||
| Q2 24 | 3.0% | 18.8% | ||
| Q1 24 | -8.4% | 21.3% |
资本支出强度NGVTTECH
| Q4 25 | 12.7% | — | ||
| Q3 25 | 3.6% | — | ||
| Q2 25 | 3.3% | 1.5% | ||
| Q1 25 | 3.5% | 3.2% | ||
| Q4 24 | 18.4% | 2.3% | ||
| Q3 24 | 5.4% | 3.2% | ||
| Q2 24 | 4.6% | 5.9% | ||
| Q1 24 | 4.9% | 5.4% |
现金转化率NGVTTECH
| Q4 25 | — | — | ||
| Q3 25 | 2.98× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 1.24× | 1.82× | ||
| Q4 24 | 3.89× | 2.42× | ||
| Q3 24 | — | 1.90× | ||
| Q2 24 | — | 1.86× | ||
| Q1 24 | — | 1.65× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NGVT
| Performance Materials | $151.2M | 82% |
| Advanced Polymer Technologies Segment | $36.5M | 20% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
